Patents-Review.com
🔗 Permalink
Assignee profile:

BIOALLIANCE PHARMA

City:

Paris

Country:

France

Published Applications:

16

Last publication date:

2013-11-14

Patent Grants:

10

Last grant date:

2014-07-29

Top Inventors for applications by BIOALLIANCE PHARMA

These are the the leading inventors for applications assigned to BIOALLIANCE PHARMA:

Recent patent applications by BIOALLIANCE PHARMA

BIOALLIANCE PHARMA based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-11-14 ✅ Patent 8,791,127 granted on 2014-07-29
US20130303556A1
Human necessities

Mucosal bioadhesive slow release carrier for delivering active principles

 #2 | 2012-12-27 ✅ Patent 8,747,896 granted on 2014-06-10
US20120329817A1
Human necessities

Mucosal bioadhesive slow release carrier for delivering active principles

 #3 | 2012-12-27
US20120326350A1
Human necessities

MUCOSAL BIOADHESIVE SLOW RELEASE CARRIER FOR DELIVERING ACTIVE PRINCIPLES

 #4 | 2011-09-15
US20110224242A1
Chemistry; metallurgy

STYRLYQUINOLINES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC USES

 #5 | 2011-06-09 ✅ Patent 8,592,434 granted on 2013-11-26
US20110136837A1
Human necessities

Mucoadhesive buccal tablets for the treatment of orofacial herpes

 #6 | 2010-10-21 ✅ Patent 8,211,466 granted on 2012-07-03
US20100266667A1
Human necessities

Mucosal bioadhesive slow release carrier for delivering active principles

 #7 | 2010-04-08
US20100087454A1
Human necessities

MUCOSAL BIOADHESIVE SLOW RELEASE CARRIER FOR DELIVERING ACTIVE PRINCIPLES

 #8 | 2009-11-19
US20090286720A1
Chemistry; metallurgy

PHARMACEUTICAL COMPOSITION FOR THE DIAGNOSIS, PREVENTION OR TREATMENT OF A TUMORAL PATHOLOGY COMPRISING AN AGENT MODULATING THE POLYMERIZATION STATE OF ACTIN

 #9 | 2009-07-02
US20090169511A1
Human necessities

Mucosal Bioadhesive SLow Release Carrier for Delivering Active Principles

 #10 | 2009-05-28
US20090137477A1
Human necessities

Treatment of oropharyngeal candidiasis in cancer patients

 #11 | 2008-01-31 ✅ Patent 8,227,435 granted on 2012-07-24
US20080027018A1
Chemistry; metallurgy

Electrotransfer of nucleic acid into tissue cells

 #12 | 2006-07-27 ✅ Patent 7,491,505 granted on 2009-02-17
US20060166289A1
Physics

Method for analyzing tumor aggressivity comprising measurement of polymerized actin

 #13 | 2006-06-22 ✅ Patent 8,062,669 granted on 2011-11-22
US20060134220A1
Human necessities

Vectorization system comprising nanoparticles of homogenous size of at least one polymer and at least one positively charged polysaccharide and method for the preparation thereof

 #14 | 2006-06-20 ✅ Patent 7,064,133 granted on 2006-06-20
US10492088
-

Quinoline derivatives process of synthesis and medicaments containing these derivatives

 #15 | 2005-09-22 ✅ Patent 7,651,698 granted on 2010-01-26
US20050208129A1
Human necessities

Prolonged release bioadhesive therapeutic systems

 #16 | 2005-07-12 ✅ Patent 6,916,485 granted on 2005-07-12
US10307938
-

Prolonged release bioadhesive therapeutic systems

Also check out BioAlliance Pharma's (Paris, France) applicant profile with 1 patent applications submitted.

AssigneeID:

195816 ⎘